Viatris Inc(NASDAQ:VTRS) 
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. It provides access to medicines, advance sustainable operations, develop innovative solutions and leverage its collective expertise to connect more people to more products and serv...
Website: https://www.viatris.com/
Founded: 2020
Full Time Employees: 45,000
Sector: Finance and Insurance
Industry: Investment Advice
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues: | ||||||||||||||||||||||
net sales | 3,509,700,000 | 3,690,700,000 | 3,747,500,000 | 3,569,000,000 | 3,243,200,000 | 3,515,400,000 | 3,738,000,000 | 3,785,900,000 | 3,653,500,000 | 3,825,900,000 | 3,933,900,000 | 3,909,500,000 | 3,719,100,000 | 3,867,100,000 | 4,067,400,000 | 4,105,400,000 | 4,178,200,000 | 4,331,300,000 | 4,520,500,000 | 4,561,700,000 | 4,400,100,000 | |
yoy | 8.22% | 4.99% | 0.25% | -5.73% | -11.23% | -8.12% | -4.98% | -3.16% | -1.76% | -1.07% | -3.28% | -4.77% | -10.99% | -10.72% | -10.02% | -10.00% | -5.04% | |||||
qoq | -4.90% | -1.52% | 5.00% | 10.05% | -7.74% | -5.96% | -1.27% | 3.62% | -4.51% | -2.75% | 0.62% | 5.12% | -3.83% | -4.92% | -0.93% | -1.74% | -3.53% | -4.19% | -0.90% | 3.67% | ||
other revenues | 7,300,000 | 12,900,000 | 12,400,000 | 13,100,000 | 11,100,000 | 12,700,000 | 13,200,000 | 10,700,000 | 9,900,000 | 11,400,000 | 8,000,000 | 9,100,000 | 10,000,000 | 8,900,000 | 10,800,000 | 11,400,000 | 13,500,000 | 10,300,000 | 16,100,000 | 16,100,000 | 30,200,000 | |
total revenues | 3,517,000,000 | 3,703,600,000 | 3,759,900,000 | 3,582,100,000 | 3,254,300,000 | 3,528,100,000 | 3,751,200,000 | 3,796,600,000 | 3,663,400,000 | 3,837,300,000 | 3,941,900,000 | 3,918,600,000 | 3,729,100,000 | 3,876,000,000 | 4,078,200,000 | 4,116,800,000 | 4,191,700,000 | 4,341,600,000 | 4,536,600,000 | 4,577,800,000 | 4,430,300,000 | |
cost of sales | 2,359,800,000 | 2,555,700,000 | 2,388,400,000 | 2,249,200,000 | 2,093,100,000 | 2,313,100,000 | 2,292,000,000 | 2,351,200,000 | 2,159,400,000 | 2,240,800,000 | 2,250,600,000 | 2,310,000,000 | 2,186,900,000 | 2,601,900,000 | 2,329,800,000 | 2,413,500,000 | 2,420,500,000 | 2,795,200,000 | 2,962,500,000 | 3,250,100,000 | 3,303,000,000 | |
gross profit | 1,157,200,000 | 1,147,900,000 | 1,371,500,000 | 1,332,900,000 | 1,161,200,000 | 1,215,000,000 | 1,459,200,000 | 1,445,400,000 | 1,504,000,000 | 1,596,500,000 | 1,691,300,000 | 1,608,600,000 | 1,542,200,000 | 1,274,100,000 | 1,748,400,000 | 1,703,300,000 | 1,771,200,000 | 1,546,400,000 | 1,574,100,000 | 1,327,700,000 | 1,127,300,000 | |
yoy | -0.34% | -5.52% | -6.01% | -7.78% | -22.79% | -23.90% | -13.72% | -10.15% | -2.48% | 25.30% | -3.27% | -5.56% | -12.93% | -17.61% | 11.07% | 28.29% | 57.12% | |||||
qoq | 0.81% | -16.30% | 2.90% | 14.79% | -4.43% | -16.74% | 0.95% | -3.90% | -5.79% | -5.61% | 5.14% | 4.31% | 21.04% | -27.13% | 2.65% | -3.83% | 14.54% | -1.76% | 18.56% | 17.78% | ||
gross margin % | 32.97% | 31.10% | 36.60% | 37.35% | 35.80% | 34.56% | 39.04% | 38.18% | 41.17% | 41.73% | 42.99% | 41.15% | 41.47% | 32.95% | 42.99% | 41.49% | 42.39% | 35.70% | 34.82% | 29.11% | 25.62% | |
operating expenses: | ||||||||||||||||||||||
research and development | 248,600,000 | 274,700,000 | 250,400,000 | 218,800,000 | 222,000,000 | 206,500,000 | 198,400,000 | 204,100,000 | 199,700,000 | 202,800,000 | 211,200,000 | 208,300,000 | 182,900,000 | 182,400,000 | 174,900,000 | 162,600,000 | 142,300,000 | 267,200,000 | 152,100,000 | 147,700,000 | 184,100,000 | |
acquired ipr&d | 6,000,000 | 38,300,000 | 10,000,000 | 30,000,000 | -7,800,000 | 6,100,000 | 94,300,000 | 1,000,000 | 10,200,000 | |||||||||||||
selling, general and administrative | 928,800,000 | 1,030,700,000 | 886,600,000 | 928,700,000 | 948,100,000 | 1,046,700,000 | 1,003,400,000 | 1,358,000,000 | 1,017,500,000 | 1,605,800,000 | 1,053,500,000 | 1,031,900,000 | 958,900,000 | 1,265,400,000 | 1,017,300,000 | 981,100,000 | 915,300,000 | 1,082,900,000 | 1,055,000,000 | 1,204,800,000 | 1,186,500,000 | |
impairment of goodwill | 2,936,800,000 | |||||||||||||||||||||
litigation settlements and other contingencies | 53,500,000 | -3,100,000 | 55,700,000 | -47,600,000 | -73,500,000 | 111,600,000 | 31,500,000 | 131,000,000 | 76,800,000 | 148,100,000 | -26,100,000 | -11,000,000 | 600,000 | -8,800,000 | -3,900,000 | 10,900,000 | 6,200,000 | 273,900,000 | 9,400,000 | 23,000,000 | 22,900,000 | |
total operating expenses | 1,236,900,000 | 1,340,600,000 | 1,192,700,000 | 1,099,900,000 | 4,043,400,000 | 1,394,800,000 | 1,233,300,000 | 1,685,300,000 | 1,300,100,000 | 2,051,000,000 | 1,239,600,000 | 1,239,400,000 | 1,142,400,000 | 1,475,400,000 | 1,188,300,000 | 1,154,600,000 | 1,063,800,000 | 1,624,000,000 | 1,216,500,000 | 1,375,500,000 | 1,393,500,000 | |
income from operations | -79,700,000 | |||||||||||||||||||||
yoy | ||||||||||||||||||||||
qoq | ||||||||||||||||||||||
operating margin % | -2.27% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
interest expense | 120,100,000 | 119,600,000 | 119,600,000 | 116,600,000 | 115,500,000 | 120,200,000 | 145,600,000 | 145,800,000 | 138,400,000 | 140,900,000 | 141,500,000 | 143,700,000 | 147,000,000 | 147,100,000 | 153,200,000 | 145,900,000 | 146,200,000 | 148,200,000 | 151,900,000 | 167,100,000 | 169,000,000 | |
other expense | 47,500,000 | 30,700,000 | 67,100,000 | 333,500,000 | 99,300,000 | 6,100,000 | -67,350,000 | -92,000,000 | -107,500,000 | -69,900,000 | -1,817,300,000 | -20,600,000 | 13,500,000 | 33,700,000 | -21,900,000 | 5,800,000 | 4,200,000 | 6,100,000 | ||||
income before income taxes | -247,300,000 | -217,100,000 | ||||||||||||||||||||
income tax benefit | -423,700,000 | |||||||||||||||||||||
net earnings | 176,400,000 | -340,100,000 | -128,200,000 | -3,042,000,000 | -516,500,000 | 94,800,000 | -326,400,000 | 113,900,000 | -765,600,000 | 331,600,000 | 264,000,000 | 224,700,000 | 1,011,200,000 | 354,300,000 | 313,900,000 | 399,200,000 | -263,800,000 | 311,500,000 | -279,200,000 | -1,037,600,000 | ||
yoy | -105.80% | -34.15% | -235.23% | -2770.76% | -32.54% | -71.41% | -223.64% | -49.31% | -175.71% | -6.41% | -15.90% | -43.71% | -483.32% | 13.74% | -212.43% | -138.47% | ||||||
qoq | -151.87% | 165.29% | 488.96% | -644.83% | -129.04% | -386.57% | -114.88% | -330.88% | 25.61% | 17.49% | -77.78% | 185.41% | 12.87% | -21.37% | -251.33% | -184.69% | -211.57% | -73.09% | ||||
net income margin % | 5.03% | -9.22% | -3.42% | 0% | -93.80% | -14.69% | 2.54% | -8.62% | 3.12% | -20.01% | 8.43% | 6.75% | 6.04% | 26.15% | 8.71% | 7.65% | 9.55% | -6.09% | 6.89% | -6.12% | -23.58% | |
earnings per share attributable to viatris inc. shareholders | ||||||||||||||||||||||
basic | 0.15 | -0.3 | -0.11 | -2.55 | -0.43 | 0.08 | -0.27 | 0.1 | -0.63 | 0.28 | 0.22 | 0.19 | 0.83 | 0.29 | 0.26 | 0.33 | -0.22 | 0.26 | -0.23 | -0.86 | ||
diluted | 0.15 | -0.3 | -0.11 | -2.55 | -0.43 | 0.08 | -0.27 | 0.09 | -0.63 | 0.27 | 0.22 | 0.19 | 0.83 | 0.29 | 0.26 | 0.33 | -0.22 | 0.26 | -0.23 | -0.86 | ||
weighted-average shares outstanding: | ||||||||||||||||||||||
basic | 1,155.4 | 1,170.7 | 1,164.6 | 1,173 | 1,192.4 | 1,193.3 | 1,193.5 | 1,191.1 | 1,195.2 | 1,200.3 | 1,199.5 | 1,199 | 1,202.5 | 1,212.1 | 1,212.5 | 1,212.3 | 1,210.5 | 1,208.8 | 1,209.3 | 1,208.8 | 1,207.5 | |
diluted | 1,175.3 | 1,170.7 | 1,164.6 | 1,173 | 1,192.4 | 1,193.3 | 1,200.4 | 1,191.1 | 1,209.5 | 1,206.9 | 1,207.6 | 1,203.5 | 1,205.6 | 1,217.4 | 1,218.1 | 1,217.1 | 1,213.1 | 1,208.8 | 1,212.6 | 1,208.8 | 1,207.5 | |
earnings from operations | -192,700,000 | 178,800,000 | 233,000,000 | -2,882,200,000 | -179,800,000 | 225,900,000 | -239,900,000 | 203,900,000 | -454,500,000 | 451,700,000 | 369,200,000 | 399,800,000 | -201,300,000 | 560,100,000 | 548,700,000 | 707,400,000 | -77,600,000 | 357,600,000 | -47,800,000 | -266,200,000 | ||
earnings before income taxes | -343,000,000 | -7,900,000 | -3,097,000,000 | -526,500,000 | 90,500,000 | -391,800,000 | 204,600,000 | -855,000,000 | 402,200,000 | 333,000,000 | 322,700,000 | 1,468,900,000 | 427,500,000 | 389,300,000 | 527,500,000 | -203,900,000 | 199,900,000 | -219,100,000 | -441,300,000 | |||
income tax provision | -2,900,000 | 120,300,000 | -212,500,000 | -55,000,000 | -10,000,000 | -4,300,000 | -65,400,000 | 90,700,000 | -89,400,000 | 70,600,000 | 69,000,000 | 98,000,000 | 457,700,000 | 73,200,000 | 75,400,000 | 128,300,000 | 59,900,000 | -111,600,000 | 60,100,000 | 596,300,000 | ||
net income | -4,600,000 | |||||||||||||||||||||
loss per share attributable to viatris inc. shareholders | ||||||||||||||||||||||
basic | ||||||||||||||||||||||
diluted | ||||||||||||||||||||||
other income | -35,800,000 | -10,200,000 | -139,100,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-27 | 2020-06-28 | 2020-03-29 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||
cash and cash equivalents | 1,804,200,000 | 1,322,400,000 | 975,300,000 | 566,400,000 | 755,000,000 | 734,800,000 | 1,878,700,000 | 917,200,000 | 1,014,600,000 | 991,900,000 | 1,309,600,000 | 629,200,000 | 506,600,000 | 1,259,900,000 | 646,700,000 | 664,700,000 | 752,400,000 | 701,200,000 | 756,600,000 | 673,900,000 | 806,900,000 | 844,400,000 | ||||
accounts receivable | 3,076,300,000 | 3,031,300,000 | 3,371,600,000 | 3,258,100,000 | 3,125,700,000 | 3,221,300,000 | 3,717,400,000 | 3,566,900,000 | 3,632,000,000 | 3,700,400,000 | 3,738,500,000 | 3,607,300,000 | 3,497,500,000 | 3,814,500,000 | 3,333,900,000 | 3,736,200,000 | 4,093,900,000 | 4,266,400,000 | 4,345,500,000 | 4,478,700,000 | 4,529,000,000 | 4,843,800,000 | ||||
inventories | 3,927,000,000 | 3,999,200,000 | 4,111,400,000 | 4,264,300,000 | 4,096,400,000 | 3,854,100,000 | 4,084,600,000 | 3,942,100,000 | 3,823,200,000 | 3,469,700,000 | 3,671,900,000 | 3,641,500,000 | 3,664,300,000 | 3,519,500,000 | 3,380,400,000 | 3,612,500,000 | 3,797,300,000 | 3,977,700,000 | 4,081,900,000 | 4,487,600,000 | 4,942,200,000 | 5,471,900,000 | ||||
prepaid expenses and other current assets | 2,109,300,000 | 1,436,300,000 | 1,493,100,000 | 1,685,800,000 | 1,645,300,000 | 1,710,500,000 | 1,627,000,000 | 1,757,000,000 | 1,933,300,000 | 2,028,100,000 | 1,784,700,000 | 1,725,100,000 | 1,763,600,000 | 1,811,200,000 | 1,700,400,000 | 1,697,700,000 | 1,763,600,000 | 1,957,600,000 | 2,124,400,000 | 2,109,600,000 | 2,040,400,000 | 1,707,400,000 | ||||
total current assets | 10,916,800,000 | 9,789,200,000 | 9,951,400,000 | 9,774,600,000 | 9,622,400,000 | 9,520,700,000 | 11,307,700,000 | 11,792,100,000 | 12,923,500,000 | 12,976,100,000 | 10,932,000,000 | 9,778,000,000 | 9,630,300,000 | 10,635,400,000 | 10,487,800,000 | 11,176,500,000 | 11,744,300,000 | 10,902,900,000 | 11,308,400,000 | 11,749,800,000 | 12,318,500,000 | 12,867,500,000 | 11,413,000,000 | 11,411,800,000 | ||
property, plant and equipment | 2,527,900,000 | 2,614,000,000 | 2,626,200,000 | 2,642,600,000 | 2,635,600,000 | 2,666,100,000 | 2,676,900,000 | 2,662,600,000 | 2,708,200,000 | 2,759,600,000 | 2,926,600,000 | 2,983,200,000 | 3,007,800,000 | 3,024,500,000 | 3,039,000,000 | 3,083,900,000 | 3,150,200,000 | 3,188,600,000 | 3,114,000,000 | 3,171,400,000 | 3,246,900,000 | 3,459,900,000 | ||||
intangible assets | 14,482,300,000 | 15,102,100,000 | 15,722,900,000 | 16,323,800,000 | 16,662,300,000 | 17,070,900,000 | 17,978,900,000 | 18,419,000,000 | 19,133,700,000 | 19,181,100,000 | 21,280,500,000 | 22,084,400,000 | 22,701,600,000 | 22,607,100,000 | 23,013,300,000 | 24,101,100,000 | 25,251,800,000 | 26,134,200,000 | 26,987,000,000 | 27,863,700,000 | 28,489,600,000 | 29,683,200,000 | ||||
goodwill | 6,692,400,000 | 6,754,700,000 | 6,730,800,000 | 6,748,300,000 | 6,462,100,000 | 9,133,300,000 | 9,561,700,000 | 9,325,900,000 | 9,693,500,000 | 9,867,100,000 | 10,278,100,000 | 10,532,500,000 | 10,573,200,000 | 10,425,800,000 | 10,054,600,000 | 10,523,000,000 | 10,978,800,000 | 12,113,700,000 | 12,169,500,000 | 11,990,400,000 | 11,907,300,000 | 12,347,000,000 | ||||
deferred income tax benefit | 1,109,200,000 | 1,061,200,000 | 999,000,000 | 924,300,000 | 817,600,000 | 753,000,000 | 763,100,000 | 685,300,000 | 653,200,000 | 692,900,000 | 930,400,000 | 966,000,000 | 959,100,000 | 925,900,000 | 1,104,000,000 | 1,243,200,000 | 1,285,800,000 | 1,332,700,000 | 1,997,300,000 | 2,147,900,000 | ||||||
other assets | 1,106,000,000 | 1,871,900,000 | 1,890,100,000 | 1,997,900,000 | 2,274,900,000 | 2,356,900,000 | 2,465,800,000 | 2,445,100,000 | 2,231,600,000 | 2,208,700,000 | 2,395,000,000 | 2,351,100,000 | 2,418,200,000 | 2,403,500,000 | 963,900,000 | 997,400,000 | 1,056,000,000 | 1,170,700,000 | 1,039,600,000 | 1,025,100,000 | 1,019,600,000 | 1,047,500,000 | ||||
total assets | 36,834,600,000 | 37,193,100,000 | 37,920,400,000 | 38,411,500,000 | 38,474,900,000 | 41,500,900,000 | 44,754,100,000 | 45,330,000,000 | 47,343,700,000 | 47,685,500,000 | 48,742,600,000 | 48,695,200,000 | 49,290,200,000 | 50,022,200,000 | 48,662,600,000 | 51,125,100,000 | 53,466,900,000 | 54,842,800,000 | 56,070,400,000 | 57,984,100,000 | 58,979,200,000 | 61,553,000,000 | 11,413,000,000 | 11,411,800,000 | ||
liabilities and equity | ||||||||||||||||||||||||||
liabilities | ||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||
accounts payable | 1,749,400,000 | 1,754,100,000 | 1,793,400,000 | 1,782,600,000 | 1,988,400,000 | 1,853,700,000 | 1,925,900,000 | 1,957,500,000 | 2,196,900,000 | 1,938,200,000 | 1,989,100,000 | 1,962,000,000 | 1,957,500,000 | 1,766,600,000 | 1,310,500,000 | 1,670,100,000 | 1,499,600,000 | 1,657,400,000 | 1,659,600,000 | 1,800,200,000 | 2,043,200,000 | 1,904,200,000 | ||||
income taxes payable | 124,000,000 | 93,400,000 | 192,700,000 | 284,100,000 | 117,700,000 | 148,400,000 | 226,800,000 | 206,900,000 | 158,100,000 | 244,500,000 | 279,600,000 | 106,700,000 | 125,700,000 | 177,800,000 | 236,900,000 | 198,000,000 | 636,000,000 | 752,000,000 | 288,600,000 | |||||||
current portion of long-term debt and other long-term obligations | 1,931,100,000 | 1,933,300,000 | 1,951,900,000 | 1,680,700,000 | 8,500,000 | 8,300,000 | 1,446,700,000 | 2,367,400,000 | 1,898,100,000 | 1,943,400,000 | 1,307,400,000 | 1,334,400,000 | 508,700,000 | 1,259,100,000 | 763,800,000 | 768,200,000 | 2,606,100,000 | 1,877,500,000 | 1,908,100,000 | 2,184,400,000 | 2,300,200,000 | 2,308,500,000 | ||||
other current liabilities | 3,129,800,000 | 3,282,900,000 | 3,618,800,000 | 3,670,100,000 | 3,629,800,000 | 3,724,700,000 | 3,855,700,000 | 3,233,800,000 | 3,281,700,000 | 3,393,900,000 | 3,316,200,000 | 3,046,100,000 | 3,192,800,000 | 3,440,900,000 | 3,504,700,000 | 3,812,400,000 | 4,426,300,000 | 4,619,600,000 | 4,631,300,000 | 4,211,500,000 | 4,845,800,000 | 4,960,700,000 | 79,000,000 | 27,800,000 | ||
total current liabilities | 6,810,300,000 | 7,094,300,000 | 7,364,100,000 | 7,133,400,000 | 5,720,100,000 | 5,779,400,000 | 7,512,400,000 | 7,709,200,000 | 7,759,900,000 | 7,777,400,000 | 6,834,000,000 | 6,523,800,000 | 6,108,100,000 | 6,746,200,000 | 6,521,400,000 | 7,681,200,000 | 9,642,900,000 | 9,884,400,000 | 10,103,900,000 | 10,132,600,000 | 9,978,100,000 | 10,562,900,000 | 79,000,000 | 27,800,000 | ||
long-term debt | 12,413,500,000 | 12,480,600,000 | 12,487,600,000 | 12,791,600,000 | 14,177,500,000 | 14,038,900,000 | 14,303,400,000 | 14,731,200,000 | 16,072,500,000 | 16,188,100,000 | 17,076,900,000 | 17,246,000,000 | 18,069,400,000 | 18,015,200,000 | 18,724,500,000 | 19,206,400,000 | 18,762,500,000 | 19,717,100,000 | 19,854,300,000 | 20,917,000,000 | 22,102,200,000 | 22,429,200,000 | 11,535,000,000 | 11,385,200,000 | ||
deferred income tax liability | 870,600,000 | 892,000,000 | 1,028,200,000 | 1,080,800,000 | 1,082,500,000 | 1,107,900,000 | 1,276,600,000 | 1,573,800,000 | 1,671,900,000 | 1,735,700,000 | 2,319,000,000 | 2,407,800,000 | 2,465,000,000 | 2,432,000,000 | 2,489,300,000 | 2,617,900,000 | 2,729,500,000 | 2,815,000,000 | 2,918,000,000 | 3,485,700,000 | 3,014,600,000 | 3,123,700,000 | ||||
other long-term obligations | 2,082,500,000 | 2,014,900,000 | 1,822,900,000 | 1,835,200,000 | 1,844,400,000 | 1,939,200,000 | 1,869,300,000 | 1,795,800,000 | 1,825,100,000 | 1,516,900,000 | 1,647,100,000 | 1,674,300,000 | 1,719,800,000 | 1,756,500,000 | 1,745,100,000 | 1,814,200,000 | 1,884,300,000 | 1,933,600,000 | 2,052,900,000 | 2,241,900,000 | 2,469,600,000 | 2,483,100,000 | ||||
total liabilities | 22,176,900,000 | 22,481,800,000 | 22,702,800,000 | 22,841,000,000 | 22,824,500,000 | 22,865,400,000 | 24,961,700,000 | 25,810,000,000 | 27,329,400,000 | 27,218,100,000 | 27,877,000,000 | 27,851,900,000 | 28,362,300,000 | 28,949,900,000 | 29,480,300,000 | 31,319,700,000 | 33,019,200,000 | 34,350,100,000 | 34,929,100,000 | 36,777,200,000 | 37,564,500,000 | 38,598,900,000 | 11,614,000,000 | 11,413,000,000 | ||
equity | ||||||||||||||||||||||||||
viatris inc. shareholders’ equity | ||||||||||||||||||||||||||
common stock: 0.01 par value... | 12,600,000 | 12,500,000 | 12,500,000 | 12,500,000 | 12,400,000 | 12,300,000 | 12,300,000 | 12,300,000 | 12,300,000 | 12,200,000 | 12,200,000 | 12,200,000 | 12,200,000 | 12,100,000 | 12,100,000 | 12,100,000 | 12,100,000 | 12,100,000 | ||||||||
additional paid-in capital | 18,663,900,000 | 18,801,300,000 | 18,890,700,000 | 18,998,200,000 | 18,960,800,000 | 18,921,600,000 | 18,888,700,000 | 18,853,300,000 | 18,839,800,000 | 18,814,700,000 | 18,760,700,000 | 18,719,400,000 | 18,679,600,000 | 18,645,800,000 | 18,616,800,000 | 18,585,700,000 | 18,555,100,000 | 18,536,100,000 | 18,514,100,000 | 18,489,900,000 | 18,464,600,000 | 18,438,800,000 | -31,000,000 | |||
retained deficit | -211,900,000 | |||||||||||||||||||||||||
accumulated other comprehensive loss | -2,799,800,000 | -2,707,000,000 | -2,713,200,000 | -2,664,400,000 | -2,870,900,000 | -3,212,900,000 | -2,686,300,000 | -2,975,200,000 | -2,941,000,000 | -2,747,400,000 | -3,208,500,000 | -3,005,600,000 | -2,764,600,000 | -2,761,200,000 | -3,759,100,000 | -2,899,200,000 | -2,061,000,000 | -1,744,300,000 | -1,471,900,000 | -1,205,000,000 | -1,385,600,000 | -858,000,000 | ||||
less: treasury stock — at cost | ||||||||||||||||||||||||||
common stock shares: 94,176,848 as of march 31, 2026 and december 31, 2025 | 1,007,100,000 | |||||||||||||||||||||||||
total equity | 14,657,700,000 | 14,711,300,000 | 15,217,600,000 | 15,570,500,000 | 15,650,400,000 | 18,635,500,000 | 19,792,400,000 | 19,520,000,000 | 20,014,300,000 | 20,467,400,000 | 20,865,600,000 | 20,843,300,000 | 20,927,900,000 | 21,072,300,000 | 19,182,300,000 | 19,805,400,000 | 20,447,700,000 | 20,492,700,000 | 21,141,300,000 | 21,206,900,000 | 21,414,700,000 | 22,954,100,000 | ||||
total liabilities and equity | 36,834,600,000 | 37,193,100,000 | 37,920,400,000 | 38,411,500,000 | 38,474,900,000 | 41,500,900,000 | 44,754,100,000 | 45,330,000,000 | 47,343,700,000 | 47,685,500,000 | 48,742,600,000 | 48,695,200,000 | 49,290,200,000 | 50,022,200,000 | 48,662,600,000 | 51,125,100,000 | 53,466,900,000 | 54,842,800,000 | 56,070,400,000 | 57,984,100,000 | 58,979,200,000 | 61,553,000,000 | 11,413,000,000 | 11,411,800,000 | ||
retained (deficit) earnings | -388,300,000 | |||||||||||||||||||||||||
common stock shares: 94,176,848 as of december 31, 2025 and 40,483,663 as of december 31, 2024 | 1,007,200,000 | |||||||||||||||||||||||||
retained earnings | -48,200,000 | 80,000,000 | 227,900,000 | 3,418,800,000 | 4,082,000,000 | 4,133,900,000 | 4,607,500,000 | 4,639,700,000 | 5,553,000,000 | 5,369,100,000 | 5,252,500,000 | 5,175,600,000 | 4,312,500,000 | 4,106,800,000 | 3,941,500,000 | 3,688,800,000 | 4,087,000,000 | 3,909,900,000 | 4,323,600,000 | 5,361,200,000 | ||||||
common stock shares: 86,122,122 and 40,483,663 as of september 30, 2025 and december 31, 2024 | 924,200,000 | |||||||||||||||||||||||||
common stock shares: 79,334,807 and 40,483,663 as of june 30, 2025 and december 31, 2024 | 855,800,000 | |||||||||||||||||||||||||
common stock shares: 59,091,265 and 40,483,663 as of march 31, 2025 and december 31, 2024 | 679,800,000 | |||||||||||||||||||||||||
assets held for sale | 1,608,900,000 | 2,520,400,000 | 2,786,000,000 | 427,300,000 | 174,900,000 | 198,300,000 | 230,300,000 | 1,426,400,000 | 1,465,400,000 | 1,337,100,000 | ||||||||||||||||
liabilities held for sale | 32,800,000 | 234,800,000 | 275,100,000 | 14,300,000 | 335,300,000 | 285,100,000 | 277,700,000 | |||||||||||||||||||
common stock shares: 40,483,663 as of december 31, 2024 and 21,239,521 as of december 31, 2023 | 504,300,000 | |||||||||||||||||||||||||
common stock shares: 40,483,663 and 21,239,521 as of september 30, 2024 and december 31, 2023 | 504,300,000 | |||||||||||||||||||||||||
common stock shares: 40,483,663 and 21,239,521 as of june 30, 2024 and december 31, 2023 | 504,300,000 | |||||||||||||||||||||||||
common stock shares: 40,483,663 and 21,239,521 as of march 31, 2024 and december 31, 2023 | 504,300,000 | |||||||||||||||||||||||||
common stock shares: 21,239,521 as of december 31, 2023 | 251,800,000 | |||||||||||||||||||||||||
short-term borrowings | 100,000 | 23,200,000 | 204,600,000 | 500,400,000 | 1,019,700,000 | 655,400,000 | 1,493,000,000 | 1,706,900,000 | 1,300,500,000 | 36,900,000 | 1,100,900,000 | |||||||||||||||
common stock shares: 21,239,521 as of september 30, 2023 | 251,800,000 | |||||||||||||||||||||||||
common stock shares: 21,239,521 as of june 30, 2023 | 251,800,000 | |||||||||||||||||||||||||
common stock shares: 21,239,521 as of march 31, 2023 | 251,800,000 | |||||||||||||||||||||||||
deferred income tax benefit - noncurrent | 1,451,900,000 | 2,183,700,000 | ||||||||||||||||||||||||
common stock — par value 0.01 per share... | ||||||||||||||||||||||||||
shares authorized: 3,000,000,000 as of september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||
shares issued and outstanding: 1,209,378,962 and 1,206,895,644 as of september 30, 2021 and december 31, 2020 | 12,100,000 | |||||||||||||||||||||||||
shares authorized: 3,000,000,000 as of june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||
shares issued: 1,209,212,338 and 1,206,895,644 as of june 30, 2021 and december 31, 2020 | 12,100,000 | |||||||||||||||||||||||||
shares authorized: 3,000,000,000 as of march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||
shares issued: 1,208,530,970 and 1,206,895,644 as of march 31, 2021 and december 31, 2020 | 12,100,000 | |||||||||||||||||||||||||
shares authorized: 3,000,000,000 and 1,200,000,000 as of december 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||
shares issued: 1,206,895,644 and 540,746,871 as of december 31, 2020 and december 31, 2019 | 12,100,000 | |||||||||||||||||||||||||
ordinary shares: 24,598,074 as of december 31, 2019 | ||||||||||||||||||||||||||
restricted short-term investments | 11,413,000,000 | 11,411,600,000 | ||||||||||||||||||||||||
other current assets | 200,000 | |||||||||||||||||||||||||
commitments and contingencies | ||||||||||||||||||||||||||
common stock, 0.01 par value... | 1 | 1 | ||||||||||||||||||||||||
due from shareholder | -1 | |||||||||||||||||||||||||
retained earnings/ | -170,000,000 | |||||||||||||||||||||||||
accumulated other comprehensive income | ||||||||||||||||||||||||||
total upjohn inc. shareholder’s equity/ | -201,000,000 | |||||||||||||||||||||||||
accumulated other comprehensive income/ | ||||||||||||||||||||||||||
total upjohn inc. shareholder’s equity | ||||||||||||||||||||||||||
balance, january 1, 2020 | 100 | |||||||||||||||||||||||||
net income | ||||||||||||||||||||||||||
other comprehensive income/(loss), net of tax | ||||||||||||||||||||||||||
balance, march 29, 2020 | 100 | |||||||||||||||||||||||||
initial capitalization, february 14, 2019 | ||||||||||||||||||||||||||
balance, december 31, 2019 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-27 | 2020-06-28 | 2020-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||
net earnings | 176,400,000 | -3,042,000,000 | -516,500,000 | 94,800,000 | -326,400,000 | 113,900,000 | -765,600,000 | 331,600,000 | 264,000,000 | 224,700,000 | 1,011,200,000 | 354,300,000 | 313,900,000 | 399,200,000 | -263,800,000 | 311,500,000 | -279,200,000 | -1,037,600,000 | |||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||
depreciation and amortization | 676,100,000 | 766,800,000 | 688,500,000 | 678,300,000 | 664,700,000 | 746,200,000 | 669,700,000 | 786,300,000 | 691,000,000 | 644,400,000 | 679,400,000 | 686,700,000 | 730,000,000 | 869,800,000 | 699,500,000 | 722,300,000 | 736,000,000 | 749,800,000 | 1,017,100,000 | 1,317,100,000 | 1,422,500,000 | ||||
share-based compensation expense | 48,200,000 | 49,400,000 | 36,000,000 | 37,100,000 | 55,200,000 | 32,300,000 | 32,400,000 | 34,700,000 | 46,700,000 | 55,800,000 | 43,100,000 | 39,200,000 | 42,600,000 | 29,600,000 | 29,100,000 | 29,400,000 | 28,300,000 | 22,500,000 | 25,000,000 | 31,000,000 | 32,700,000 | ||||
deferred income tax benefit | -69,700,000 | -248,200,000 | -137,200,000 | -47,500,000 | -43,600,000 | -248,900,000 | -312,400,000 | -154,400,000 | -51,900,000 | -85,000,000 | -68,200,000 | -26,700,000 | |||||||||||||
loss on disposal of business | 13,900,000 | 21,900,000 | -1,600,000 | 43,800,000 | 36,900,000 | 103,700,000 | 107,400,000 | ||||||||||||||||||
acquired ipr&d | 6,000,000 | 35,800,000 | 0 | 0 | 15,000,000 | 25,000,000 | 0 | -7,500,000 | -5,200,000 | ||||||||||||||||
impairment of goodwill | 0 | 0 | 0 | 2,936,800,000 | |||||||||||||||||||||
other non-cash items | 182,300,000 | 133,500,000 | 109,500,000 | 522,500,000 | 203,800,000 | 157,300,000 | 64,300,000 | 79,100,000 | -3,000,000 | 647,500,000 | -95,000,000 | 13,300,000 | 29,600,000 | 241,300,000 | 189,200,000 | -34,000,000 | 37,800,000 | 123,600,000 | 84,700,000 | 170,200,000 | 33,300,000 | ||||
litigation settlements and other contingencies | 58,000,000 | 4,900,000 | 51,900,000 | -27,600,000 | -69,400,000 | 28,900,000 | 31,600,000 | 133,700,000 | 80,300,000 | 141,400,000 | -48,300,000 | -8,700,000 | 2,400,000 | -7,600,000 | -4,100,000 | 4,800,000 | 5,200,000 | 273,700,000 | 7,600,000 | 19,500,000 | 22,900,000 | ||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||
accounts receivable | -126,300,000 | 271,900,000 | -95,700,000 | -9,600,000 | 168,000,000 | 300,500,000 | -33,000,000 | 22,800,000 | 9,800,000 | 81,400,000 | -72,000,000 | -145,800,000 | 215,000,000 | -339,200,000 | 241,200,000 | -26,800,000 | -115,500,000 | -9,800,000 | 183,800,000 | -54,900,000 | -59,800,000 | ||||
inventories | -123,000,000 | 15,800,000 | 110,500,000 | -39,000,000 | -193,700,000 | -35,600,000 | -129,000,000 | -188,400,000 | -370,400,000 | -127,600,000 | -219,200,000 | -115,400,000 | -151,100,000 | 180,100,000 | -169,500,000 | -201,000,000 | -69,100,000 | -76,500,000 | -10,100,000 | -137,600,000 | -203,400,000 | ||||
accounts payable | 32,700,000 | 3,200,000 | -291,300,000 | 101,600,000 | -66,000,000 | -231,600,000 | 287,900,000 | 43,600,000 | 9,300,000 | 183,400,000 | -329,900,000 | 284,700,000 | -30,200,000 | -54,900,000 | -245,400,000 | 191,900,000 | |||||||||
income taxes | -463,400,000 | 125,500,000 | 128,200,000 | -246,000,000 | -120,600,000 | -67,600,000 | 268,200,000 | 21,000,000 | -2,300,000 | -47,100,000 | -7,500,000 | 31,800,000 | -53,900,000 | -4,200,000 | 11,700,000 | -49,200,000 | 67,000,000 | -24,300,000 | -337,600,000 | -832,300,000 | 494,600,000 | ||||
other operating assets and liabilities | -22,900,000 | -39,900,000 | -20,200,000 | -396,400,000 | -177,200,000 | -88,300,000 | 98,500,000 | -49,000,000 | -111,800,000 | -261,900,000 | 263,400,000 | -191,300,000 | -224,800,000 | -483,500,000 | -130,600,000 | -136,900,000 | 132,700,000 | -266,900,000 | -306,100,000 | 261,100,000 | -354,600,000 | ||||
net cash from operating activities | 388,300,000 | 815,800,000 | 744,900,000 | 219,700,000 | 535,500,000 | 482,700,000 | 826,500,000 | 379,100,000 | 614,600,000 | 479,400,000 | 834,100,000 | 514,900,000 | 971,200,000 | 142,600,000 | 869,000,000 | 802,500,000 | 1,138,500,000 | 523,100,000 | 1,085,600,000 | 559,400,000 | 848,800,000 | 1,230,800,000 | |||
cash flows from investing activities: | |||||||||||||||||||||||||
proceeds from the sale of investments | 400,000,000 | ||||||||||||||||||||||||
capital expenditures | -39,900,000 | -196,500,000 | -86,800,000 | -52,900,000 | -42,600,000 | -140,400,000 | -77,000,000 | -58,800,000 | -49,800,000 | -165,500,000 | -95,900,000 | -67,800,000 | -47,800,000 | -153,700,000 | -103,900,000 | -83,900,000 | -64,500,000 | -197,400,000 | -121,000,000 | -89,300,000 | -49,500,000 | 0 | |||
free cash flows | 348,400,000 | 619,300,000 | 658,100,000 | 166,800,000 | 492,900,000 | 342,300,000 | 749,500,000 | 320,300,000 | 564,800,000 | 313,900,000 | 738,200,000 | 447,100,000 | 923,400,000 | -11,100,000 | 765,100,000 | 718,600,000 | 1,074,000,000 | 325,700,000 | 964,600,000 | 470,100,000 | 799,300,000 | 1,230,800,000 | |||
purchase of marketable securities | -7,500,000 | -5,800,000 | -7,200,000 | -6,300,000 | -4,600,000 | -4,300,000 | -8,400,000 | -5,600,000 | -7,700,000 | -5,400,000 | -4,300,000 | -7,600,000 | -9,000,000 | -6,900,000 | -10,100,000 | -4,600,000 | -8,600,000 | -3,900,000 | -6,800,000 | -7,200,000 | -12,300,000 | ||||
proceeds from the sale of marketable securities | 7,500,000 | 5,800,000 | 7,200,000 | 6,300,000 | 4,600,000 | 4,300,000 | 8,400,000 | 5,600,000 | 7,700,000 | 5,400,000 | 4,300,000 | 7,600,000 | 9,000,000 | 6,900,000 | 10,200,000 | 4,300,000 | 8,500,000 | 3,800,000 | 6,800,000 | 6,900,000 | 12,300,000 | ||||
payments for product rights and other | -82,000,000 | -2,600,000 | -12,900,000 | -1,200,000 | -18,800,000 | -700,000 | -8,400,000 | -10,700,000 | -1,000,000 | -35,400,000 | -6,200,000 | -21,200,000 | -34,700,000 | -12,200,000 | -11,800,000 | -5,600,000 | -7,400,000 | -24,000,000 | -10,900,000 | -13,600,000 | -3,700,000 | ||||
purchases of ipr&d | -2,300,000 | ||||||||||||||||||||||||
proceeds from the sale of property, plant and equipment | 1,600,000 | 800,000 | 1,600,000 | 11,300,000 | 800,000 | 700,000 | 700,000 | ||||||||||||||||||
net cash from investing activities | 277,400,000 | -211,200,000 | -98,900,000 | -52,500,000 | -65,100,000 | -168,700,000 | 1,747,900,000 | 375,800,000 | -154,300,000 | 115,800,000 | -53,800,000 | -76,600,000 | -749,500,000 | 1,784,500,000 | -115,000,000 | -82,100,000 | -66,900,000 | -219,100,000 | -118,200,000 | -16,800,000 | 236,300,000 | 11,111,900,000 | -1,400,000 | ||
cash flows from financing activities: | |||||||||||||||||||||||||
purchase of common stock | -85,100,000 | -65,000,000 | -175,000,000 | -175,400,000 | 0 | 0 | 0 | -250,000,000 | 0 | 0 | 0 | -250,000,000 | |||||||||||||
change in short-term borrowings | -1,500,000 | 300,000 | 0 | 1,400,000 | 100,000 | -22,900,000 | -181,500,000 | 204,600,000 | -500,400,000 | -519,300,000 | 364,400,000 | -837,900,000 | -214,000,000 | 406,400,000 | 1,263,600,000 | -1,063,900,000 | |||||||||
taxes paid related to net share settlement of equity awards | -56,500,000 | 100,000 | -800,000 | -200,000 | -29,300,000 | 0 | -21,200,000 | -3,400,000 | -28,700,000 | -5,600,000 | -2,600,000 | 0 | -30,000,000 | -3,900,000 | -200,000 | -3,300,000 | -9,900,000 | -300,000 | -3,600,000 | -5,700,000 | -7,800,000 | ||||
contingent consideration payments | -7,900,000 | 0 | 0 | -1,700,000 | -11,400,000 | 0 | 0 | -20,600,000 | -10,900,000 | 0 | 0 | 0 | -8,400,000 | 0 | 0 | -3,400,000 | -15,500,000 | 0 | 0 | -2,600,000 | -26,000,000 | ||||
cash dividends paid | -139,600,000 | -138,200,000 | -139,900,000 | -139,800,000 | -143,300,000 | -143,300,000 | -143,200,000 | -145,500,000 | -142,800,000 | -144,000,000 | -143,900,000 | -143,900,000 | -143,800,000 | -145,500,000 | -145,500,000 | -145,500,000 | -145,100,000 | -133,000,000 | -133,000,000 | ||||||
issuance of common stock | 500,000 | 600,000 | 700,000 | 700,000 | 600,000 | 600,000 | 600,000 | 700,000 | 600,000 | 600,000 | 800,000 | 800,000 | 900,000 | 800,000 | 1,800,000 | ||||||||||
other items | -300,000 | -12,000,000 | -23,100,000 | -45,400,000 | -109,600,000 | 98,300,000 | 68,100,000 | 122,600,000 | 6,200,000 | -277,200,000 | 71,300,000 | 21,100,000 | 11,800,000 | 19,200,000 | -400,000 | 0 | -200,000 | -800,000 | -1,000,000 | -1,000,000 | -2,100,000 | ||||
net cash from financing activities | -203,800,000 | -236,400,000 | -228,100,000 | -362,400,000 | -467,000,000 | -1,420,200,000 | -1,636,700,000 | -847,900,000 | -425,600,000 | -926,100,000 | -97,600,000 | -303,500,000 | -974,700,000 | -1,330,600,000 | -758,700,000 | -779,600,000 | -1,009,000,000 | -349,200,000 | -877,500,000 | -685,500,000 | -1,099,800,000 | -12,017,700,000 | 400,000 | ||
effect on cash of changes in exchange rates | -4,200,000 | -23,700,000 | 17,800,000 | 6,700,000 | 16,800,000 | -37,800,000 | 23,900,000 | -4,400,000 | -12,400,000 | 12,700,000 | -2,300,000 | -14,100,000 | 1,200,000 | 15,600,000 | -14,300,000 | -28,800,000 | -11,400,000 | -10,300,000 | -7,300,000 | 8,900,000 | -22,200,000 | ||||
net increase in cash, cash equivalents and restricted cash | 457,700,000 | 344,500,000 | 20,200,000 | -1,144,000,000 | 22,300,000 | -318,200,000 | -751,800,000 | 51,200,000 | -55,500,000 | -36,900,000 | |||||||||||||||
cash, cash equivalents and restricted cash — beginning of period | 1,348,000,000 | 0 | 0 | 0 | 736,100,000 | 0 | 0 | 0 | 993,600,000 | 0 | 0 | 0 | 1,262,500,000 | 0 | 0 | 0 | 706,200,000 | 0 | 0 | 0 | 850,000,000 | ||||
cash, cash equivalents and restricted cash — end of period | 1,805,700,000 | 344,500,000 | 435,700,000 | -188,500,000 | 756,300,000 | -1,144,000,000 | 961,600,000 | -97,400,000 | 1,015,900,000 | -318,200,000 | 680,400,000 | 120,700,000 | 510,700,000 | 612,100,000 | -19,000,000 | -88,000,000 | 757,400,000 | -55,500,000 | 82,600,000 | -134,000,000 | 813,100,000 | ||||
adjustments to reconcile net earnings to net cash from operating activities: | |||||||||||||||||||||||||
trade accounts payable | |||||||||||||||||||||||||
cash paid for acquisitions, net of cash acquired | 0 | 0 | 0 | -350,000,000 | 0 | 0 | -667,700,000 | ||||||||||||||||||
proceeds from sale of property, plant and equipment | 600,000 | 300,000 | 400,000 | 600,000 | 2,200,000 | 600,000 | |||||||||||||||||||
proceeds from sale of assets and subsidiaries | -3,100,000 | 1,832,500,000 | 437,100,000 | 240,600,000 | 200,000 | 13,100,000 | |||||||||||||||||||
proceeds from issuance of long-term debt | 100,000 | 1,080,100,000 | 795,300,000 | 100,000 | 0 | 810,000,000 | -10,494,700,000 | -200,000 | |||||||||||||||||
payments of long-term debt | -1,374,300,000 | -1,537,700,000 | -500,100,000 | 0 | 0 | -750,100,000 | -700,600,000 | -1,174,900,000 | -1,786,900,000 | -100,000 | -600,000 | -1,950,000,000 | |||||||||||||
payments of financing fees | -200,000 | -300,000 | 0 | -200,000 | -300,000 | -300,000 | -900,000 | -400,000 | -500,000 | -6,300,000 | |||||||||||||||
non-contingent payments for product rights | 0 | 0 | 0 | -9,700,000 | 0 | 0 | |||||||||||||||||||
supplemental disclosures of cash flow information — | |||||||||||||||||||||||||
cash paid during the period for: | |||||||||||||||||||||||||
interest | |||||||||||||||||||||||||
net loss | -128,200,000 | ||||||||||||||||||||||||
(purchases) refunds of ipr&d | 0 | 0 | -15,000,000 | ||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -19,000,000 | ||||||||||||||||||||||||
refunds (purchases) of ipr&d | 0 | ||||||||||||||||||||||||
gain on disposal of business | -70,400,000 | ||||||||||||||||||||||||
refund of ipr&d | 5,200,000 | ||||||||||||||||||||||||
deferred income tax expense | 153,600,000 | -21,900,000 | -104,800,000 | -52,800,000 | -52,900,000 | 147,000,000 | 293,200,000 | 288,400,000 | |||||||||||||||||
loss from equity method investments | -100,000 | 9,700,000 | 17,600,000 | 16,700,000 | 17,900,000 | ||||||||||||||||||||
cash received for acquisitions, net of cash acquired | |||||||||||||||||||||||||
proceeds from the sale of assets and subsidiaries | |||||||||||||||||||||||||
gain from equity method investments | |||||||||||||||||||||||||
proceeds from the sale of assets | 700,000 | 5,100,000 | 12,500,000 | ||||||||||||||||||||||
proceeds from exercise of stock options | |||||||||||||||||||||||||
non-cash transactions: | |||||||||||||||||||||||||
common stock issued for the combination | |||||||||||||||||||||||||
cash received from acquisitions | 0 | 0 | 277,000,000 | ||||||||||||||||||||||
write off of financing fees | |||||||||||||||||||||||||
purchase of ordinary shares | |||||||||||||||||||||||||
acquisition of noncontrolling interest | |||||||||||||||||||||||||
operating activities | |||||||||||||||||||||||||
net income | -169,100,000 | ||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||
amortization of bond discount and issuance costs | 2,800,000 | ||||||||||||||||||||||||
currency remeasurement loss on euro notes | |||||||||||||||||||||||||
benefit for taxes on income | |||||||||||||||||||||||||
other changes in assets and liabilities | 72,100,000 | ||||||||||||||||||||||||
investing activities | |||||||||||||||||||||||||
net | -1,400,000 | ||||||||||||||||||||||||
financing activities | |||||||||||||||||||||||||
long-term debt issuance costs paid | -21,400,000 | ||||||||||||||||||||||||
financing activities with pfizer | |||||||||||||||||||||||||
effect of exchange-rate changes on cash and cash equivalents | |||||||||||||||||||||||||
net increase/(decrease) in cash and cash equivalents | |||||||||||||||||||||||||
cash and cash equivalents, beginning | |||||||||||||||||||||||||
cash and cash equivalents, end | |||||||||||||||||||||||||
supplemental cash flow information | |||||||||||||||||||||||||
other adjustments | |||||||||||||||||||||||||
other changes in assets and liabilities: |